Safety of statin therapy in HIV/hepatitis C virus-coinfected patients

被引：11
|
作者：
Milazzo, Laura [1 ]
Menzaghi, Barbara
Corvasce, Stefano
Bonfanti, Paolo
Rusconi, Stefano
Ridolfo, Anna Lisa
Antinori, Spinello
机构：
[1] Univ Milan, L Sacco Hosp, Dept Clin Sci, Milan, Italy
[2] L Sacco Hosp Vialba, Div Infect Dis 1, Milan, Italy
来源：
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 2007年 / 46卷 / 02期
关键词：
D O I：
10.1097/QAI.0b013e3181142e43
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：258 / 260
页数：3
相关论文
共 50 条
  • [1] Lipid abnormalities in HIV/hepatitis C virus-coinfected patients
    Bedimo, R.
    Ghurani, R.
    Nsuami, M.
    Turner, D.
    Kvanli, M-B
    Brown, G.
    Margolis, D.
    [J]. HIV MEDICINE, 2006, 7 (08) : 530 - 536
  • [2] Advances in Therapy for HIV/Hepatitis C Virus-Coinfected Patients in the Liver Transplant Setting
    Campos-Varela, Isabel
    Peters, Marion G.
    Terrault, Norah A.
    [J]. CLINICAL INFECTIOUS DISEASES, 2015, 60 (01) : 108 - 116
  • [3] The role of insulin resistance in HIV/hepatitis C virus-coinfected patients
    Eslam, Mohammed
    Lopez-Cortes, Luis F.
    Romero-Gomez, Manuel
    [J]. CURRENT OPINION IN HIV AND AIDS, 2011, 6 (06) : 553 - 558
  • [4] Hepatic safety of efavirenz in HIV/hepatitis C virus-coinfected patients with advanced liver fibrosis
    Pineda, Juan A.
    Neukam, Karin
    Mallolas, Josep
    Lopez-Cortes, Luis F.
    Carton, Jose A.
    Domingo, Pere
    Moreno, Santiago
    Iribarren, Jose A.
    Clotet, Bonaventura
    Crespo, Manuel
    de Los Santos, Ignacio
    Ortega, Enrique
    Knobel, Hernando
    Jimenez-Exposito, Maria J.
    Macias, Juan
    [J]. JOURNAL OF INFECTION, 2012, 64 (02) : 204 - 211
  • [5] HIV/Hepatitis C Virus-Coinfected Patients: Is There a Better Marker for Atherogenicity?
    Manickam, Palaniappan
    Mogrovejo, Estela
    Krishnamoorthi, Rajesh
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2013, 29 (05) : 745 - 745
  • [6] Course of Liver Fibrosis in HIV-Hepatitis C Virus-Coinfected Patients Depending on the Response to Hepatitis C Therapy
    Carton, Jose-Antonio
    Collazos, Julio
    de la Fuente, Belen
    Asensi, Victor
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2013, 29 (02) : 215 - 222
  • [7] Prevalence of risk factors for hepatitis C virus in HIV-infected and HIV/hepatitis C virus-coinfected patients
    Bollepalli, Srigayatri
    Mathieson, Kathleen
    Bay, Curt
    Hillier, Amy
    Post, John
    Van Thiel, David H.
    Nadir, Abdul
    [J]. SEXUALLY TRANSMITTED DISEASES, 2007, 34 (06) : 367 - 370
  • [8] HIV/hepatitis C virus-coinfected patients with normal alanine aminotransferase levels
    Gonzalez, SA
    Liu, RC
    Edlin, BR
    Jacobson, IM
    Talal, AH
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2006, 41 (05) : 582 - 589
  • [9] Efficacy and Safety of Pegylated Interferon plus Ribavirin in HIV and Hepatitis C Virus-Coinfected Patients with Advanced Immunosuppression
    Mira, Jose A.
    Gutierrez-Valencia, Alicia
    Gil, Ignacio De los Santos
    Merino, Dolores
    Rivero, Antonio
    Rios-Villegas, Maria J.
    Delgado, Marcial
    Gonzalez-Serrano, Mercedes
    Collado, Antonio
    Torres-Tortosa, Manuel
    Omar, Mohamed
    Angel Lopez-Ruz, Miguel
    Macias, Juan
    Arponen, Sari
    Pineda, Juan A.
    [J]. CLINICAL INFECTIOUS DISEASES, 2009, 49 (08) : E84 - E91
  • [10] HLA-E variants are associated with sustained virological response in HIV/hepatitis C virus-coinfected patients on hepatitis C virus therapy
    Guzman-Fulgencio, Maria
    Berenguer, Juan
    Rallon, Norma
    Fernandez-Rodriguez, Amanda
    Miralles, Pilar
    Soriano, Vicente
    Jimenez-Sousa, Maria A.
    Cosin, Jaime
    Medrano, Jose
    Garcia-Alvarez, Monica
    Lopez, Juan C.
    Benito, Jose M.
    Resino, Salvador
    [J]. AIDS, 2013, 27 (08) : 1231 - 1238
12345